Corneal hydration control and thickness recovery after stress-induced corneal edema are reduced in advanced FECD compared with normal corneas. Anterior corneal backscatter, which is known to be increased early in the course of FECD,
7,8 is associated with overall endothelial function and should be further investigated for its ability to estimate endothelial function in clinical practice.
Ideal control of corneal hydration requires a balance between passive barrier leakage into the cornea and active pump of solute back to the aqueous humor.
9,22 Alterations in corneal hydration can result from pump or barrier dysfunction and are known to adversely affect stromal transparency.
23 In this study, we found that corneal hydration control was impaired in clinically advanced FECD compared with normal and was associated with a delay in recovery of steady-state corneal thickness in FECD; we were unable to detect a significant difference in mild or moderate disease, although there were similar trends toward decreased PRPH. Percent recovery per hour in normal corneas (49%/h, 95% CI 41–57) was similar to that found in a previous study from our laboratory (48%/h; 95% CI 43–53) in normal, young non–contact-lens wearers.
9 Another study found lower PRPH (34%/h in normal corneas and 25%/h in FECD),
15 and these differences might be due to different experimental conditions and FECD severity. Nielsen et al.
16 found a similar amount of swelling in advanced FECD and normal corneas (approximately 44 μm or 7%); PRPH was not determined, but the percentage of swelling was significantly higher in advanced FECD compared with normal.
In our study, we defined severity of FECD according to a morphologic grading scale,
3,4 which can be easily implemented in clinical practice. Nevertheless, this grading scale is subjective, which leads to interobserver variation,
6 and does not account for the presence of subclinical corneal edema that can be present even when morphologic changes are not sufficiently advanced.
6,24 We investigated the association between corneal hydration control and various morphologic parameters, including clinical grade and its objective morphological equivalent, ECD
e,
18 corneal swelling, and corneal backscatter in an effort to provide the clinician with objective measures beyond the patient's subjective symptoms. Although all of these parameters were associated with PRPH in univariable analyses, only anterior corneal backscatter and induced swelling were associated with PRPH in a multivariable analysis. Notably, clinical grading and ECD
e, which are known to be associated,
18 and CT
ss, did not improve the prediction of PRPH. Because the range of normal corneal thickness is large,
25 measurements that fall within this range cannot discriminate well between normality and corneal edema, and thus it is not unexpected that corneal thickness did not improve the prediction of PRPH. Corneal thickness is still an important parameter in the evaluation of FECD, especially when measurements are thicker than the normal range, or when a change in corneal thickness can be documented.
Determining PRPH by the method described in this study is time-consuming and not feasible in routine clinical practice. Therefore, one of the goals of this study was to determine if any objective and easily measured variables could be used as a surrogate for corneal hydration control. Anterior corneal backscatter was the only variable that was associated with PRPH and could be measured easily and noninvasively (
Fig. 3). Anterior corneal backscatter in FECD originates from edema and ultrastructural tissue changes in the basal epithelium and anterior stroma.
7,8,26 Early improvement in backscatter after restoring endothelial function has been explained by resolution of corneal edema,
27,28 suggesting that anterior backscatter is a more sensitive indicator of subtle corneal edema than is clinical examination or pachymetry. Corneal backscatter is unrelated to corneal thickness in normal (nonedematous) corneas; by combining the steady-state data in this study with previously published data from our laboratory,
7 there was no association between central corneal thickness and standardized anterior backscatter in 23 normal eyes of subjects aged 50 years or older (
r = 0.1,
P = 0.6). In contrast, there was a weak association between central thickness and anterior backscatter in FECD (
r = 0.3,
P = 0.004;
n = 88), in which increased thickness can be attributed to corneal edema. Although there was overlap between central corneal thickness in FECD (range, 456–666 μm) and normal (range, 484–594 μm) eyes, anterior corneal backscatter greater than 2 SDs above the normal mean was present in 8 of 29 mild, 11 of 29 moderate, and 21 of 30 advanced FECD eyes, indicating the potential discriminative value of anterior backscatter. Although the presence of corneal edema can explain the association between anterior backscatter and PRPH, the relationship was not highly predictive (
R2 = 0.44), possibly because a component of backscatter originates from chronic ultrastructural tissue changes and not from edema.
28 Because corneal hydration control reflects both barrier and pump function, permeability measures might improve sensitivity and prediction of true pump function.
9
The main limitation of this study was our inability to estimate activity of the endothelial pump independent from the endothelial barrier. The PRPH provides an estimate of the net activity of both activities and pump function and can be determined only if the barrier function, based on permeability of the endothelium to a small tracer such as fluorescein, is known.
9 Unfortunately, determination of endothelial permeability to fluorescein in FECD is challenging and estimates of the barrier function have differed by a factor of 4 between studies, which led to different conclusions regarding FECD.
29,30 These variations may be from unreliable measurement of fluorescein concentration in the stroma because of increased scattered light in these corneas.
7 Also, estimates of corneal volume from central corneal thickness may be unreliable because of the abnormal thickness profile in FECD,
17 although our thickness measurements based on the entire cornea profile measured by the Scheimpflug camera were likely more representative of the cornea than thickness measured at the center by ultrasonic pachymetry. For this study, we also assumed that the difference in recovery of induced edema was solely attributed to overall endothelial function
11 and not influenced by evaporation from the anterior corneal surface. The epithelium is considerably less permeable than the endothelium, and would likely not influence this measurement significantly. Also, the epithelium of all participants remained intact during the study and the environmental conditions were controlled, minimizing potential variations in any evaporative component. The small sample size of the moderate FECD group may have limited our ability to detect a difference in PRPH from normal.
In summary, we found that corneal hydration control became impaired in advanced stages of FECD (based on morphologic grading), and that anterior corneal backscatter could provide an imperfect but notable estimate of endothelial function. Although morphologic grading is quick and simple in clinical practice, it was more helpful when penetrating keratoplasty was the procedure of choice for FECD because most surgeons waited for clinically detectable edema to be present before offering a transplant. With distinct advantages of endothelial over penetrating keratoplasty, and with knowledge that subclinical edema is present earlier in FECD, the threshold to offer a transplant has decreased. However, a simple method of estimating corneal endothelial function in these cases, in which classic biomicroscopy and pachymetric findings are not discriminatory, could help in deciding whether patients will benefit from intervention. Similarly, a simple estimate of endothelial function could be a prognostic indicator of the outcome of intraocular surgery in the setting of a compromised endothelium. Further investigation of anterior backscatter as a surrogate for endothelial function is worthwhile to better understand its role in clinical practice.